Squamous Cell Carcinoma — Trials

Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,928 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 974
Recruiting: 517
Ph III recruiting: 60
Growth YoY: +43.3%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (402)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06132191	Expanded Access Use of Cemiplimab in Patients With Solid Tumors	approved for marketing	—	—	Regeneron PharmaceuticalsINDUSTRY	0	Nov 20, 2025	clinicaltrials

Data updated 22 days agoSource updated Nov 20, 2025source: clinicaltrials